The bone marrow-expressed antimicrobial cationic peptide LL-37 enhances the responsiveness of hematopoietic stem progenitor cells to an SDF-1 gradient and accelerates their engraftment after transplantation

Leukemia

Volumn 26, Issue 4, 2012, Pages 736-745

  Wu, W ^a   Kim, C H ^a   Liu, R ^a   Kucia, M ^a,b   Marlicz, W ^b   Greco, N ^c   Ratajczak, J ^a,b   Laughlin, M J ^d   Ratajczak, M Z ^a,b  

^a University of Louisville School of Medicine   (United States)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c Cleveland Cord Blood Center   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

C1P; CXCR4; LL 37; S1P; SDF 1; stem cell homing

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CHEMOKINE RECEPTOR CXCR4; PROTEIN SERINE THREONINE KINASE; STROMAL CELL DERIVED FACTOR 1;

ACTIN POLYMERIZATION; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL ADHESION; CONTROLLED STUDY; ENGRAFTMENT; EX VIVO STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LIPID RAFT; MAMMAL CELL; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STEM CELL; STEM CELL TRANSPLANTATION; THROMBOCYTE COUNT;

EID: 84859640534     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.252     Document Type: Article

References (27)

1. Delaney C, Ratajczak MZ, Laughlin MJ. Strategies to enhance umbilical cord blood stem cell engraftment in adult patients. Exp Rev Hematol 2010; 3: 273-283.
2. Janowska-Wieczorek A, Majka M, Kijowski J, Baj-Krzyworzeka M, Reca R, Turner AR et al. Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood 2001; 98: 3143-3149.
3. Reca R, Mastellos D, Majka M, Marquez L, Ratajczak J, Franchini S et al. Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1. Blood 2003; 101: 3784-3793. (Pubitemid 36857847)
4. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood 2005; 106: 1901-1910. (Pubitemid 41291700)
5. Kimura T, Boehmler AM, Seitz G, Kuçi S, Wiesner T, Brinkmann V et al. The sphingosine 1-phosphate receptor agonist FTY720 supports CXCR4-dependent migration and bone marrow homing of human CD34+ progenitor cells. Blood 2004; 103: 4478-4486. (Pubitemid 38745973)
6. Rossi L, Manfredini R, Bertolini F, Ferrari D, Fogli M, Zini R et al. The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration. Blood 2007; 109: 533-542. (Pubitemid 46105950)
7. Hoggatt J, Pelus LM. Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor trafficking. Leukemia 2010; 24: 1993-2002.
8. Lee HM, Wu W, Wysoczynski M, Liu R, Zuba-Surma EK, Kucia M et al. Impaired mobilization of hematopoietic stem/progenitor cells in C5-deficient mice supports the pivotal involvement of innate immunity in this process and reveals novel promobilization effects of granulocytes. Leukemia 2009; 23: 2052-2062.
9. Bucki R, Leszczyñska K, Namiot A, Soko"owski W. Cathelicidin LL-37: a multitask antimicrobial peptide. Arch Immunol Ther Exp 2010; 58: 15-25.
10. Ratajczak MZ, Lee H, Wysoczynski M, Wan W, Marlicz W, Laughlin MJ et al. Novel insight into stem cell mobilization - Plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complex. Leukemia 2010; 24: 976-985.
11. Kim CH, Wu W, Wysoczynski M, Abdel-Latif A, Sunkara M, Morris A et al. Conditioning for hematopoietic transplantation activates the complement cascade and induces a proteolytic environment in bone marrow: a novel role for bioactive lipids and soluble C5b-C9 as homing factors. Leukemia 2011; e-pub ahead of print 19 July 2011; doi:10.1038/leu.2011.185.
12. Wysoczynski M, Reca R, Ratajczak J, Kucia M, Shirvaikar N, Honczarenko M et al. Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient. Blood 2005; 105: 40-48. (Pubitemid 40053061)
13. Ratajczak MZ, Reca R, Wysoczynski M, Kucia M, Baran JT, Allendorf DJ et al. Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cells. Leukemia 2004; 18: 1482-1490. (Pubitemid 39264070)
14. Wysoczynski M, Kucia M, Ratajczak J, Ratajczak MZ. Cleavage fragments of the third complement component (C3) enhance stromal derived factor-1 (SDF-1)-mediated platelet production during reactive postbleeding thrombocytosis. Leukemia 2007; 21: 973-982. (Pubitemid 46672074)
15. Méndez-Samperio P. The human cathelicidin hCAP18/LL-37: a multifunctional peptide involved in mycobacterial infections. Peptides 2010; 31: 1791-1798.
16. Le Y, Yang Y, Cui Y, Yazawa H, Gong W, Qiu C et al. Receptors for chemotactic formyl peptides as pharmacological targets. Int Immunopharmacol 2002; 2: 1-13. (Pubitemid 33086799)
17. Bengtsson NE, Kim S, Lin L, Walter GA, Scott EW. Ultra-high-field MRI real-time imaging of HSC engraftment of the bone marrow niche. Leukemia 2011; 25: 1223-1231.
18. Lee HM, Wysoczynski M, Liu R, Shin DM, Kucia M, Botto M et al. Mobilization studies in complement-deficient mice reveal that optimal AMD3100 mobilization of hematopoietic stem cells depends on complement cascade activation by AMD3100-stimulated granulocytes. Leukemia 2010; 24: 573-582.
19. Greenbaum AM, Link DC. Mechanisms of G-CSF-mediated hematopoietic stem and progenitor mobilization. Leukemia 2011; 25: 211-217.
20. Lévesque JP, Helwani FM, Winkler IG. The endosteal 'osteoblastic' niche and its role in hematopoietic stem cell homing and mobilization. Leukemia 2010; 24: 1979-1992.
21. Ratajczak J, Reca R, Kucia M, Majka M, Allendorf DJ, Baran JT et al. Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow. Blood 2004; 103: 2071-2078. (Pubitemid 38326222)
22. Lee H, Ratajczak MZ. Innate Immunity: a key player in the mobilization of hematopoietic stem/progenitor cells. Arch Immunol Ther Exp 2009; 57: 269-278.
23. Coffelt SB, Marini FC, Watson K, Zwezdaryk KJ, Dembinski JL, LaMarca HL et al. The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells. Proc Natl Acad Sci USA 2009; 106: 3806-3811.
24. Weber G, Chamorro C, Granath F, Liljegren A, Zreika S, Saidak Z et al. Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer. Breast Cancer Res 2009; 11: R6.
25. Hensel JA, Chanda D, Kumar S, Sawant A, Grizzle WE, Siegal GP et al. LL-37 as a therapeutic target for late stage prostate cancer. Prostate 2011; 71: 659-670.
26. Ciornei CD, Sigurdardottir T, Schmidtchen A, Bodelsson M. Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37. Antimicrob Agents Chemother 2005; 49: 2845-2850. (Pubitemid 40917601)
27. Zughaier SM, Svoboda P, Pohl J, Stephens DS, Shafer WM. The human host defense peptide LL-37 interacts with Neisseria meningitidis capsular polysaccharides and inhibits inflammatory mediators release. PLoS ONE 2010; 5: e13627.